BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8175774)

  • 1. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture.
    Ji ZS; Lauer SJ; Fazio S; Bensadoun A; Taylor JM; Mahley RW
    J Biol Chem; 1994 May; 269(18):13429-36. PubMed ID: 8175774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia.
    Ji ZS; Fazio S; Mahley RW
    J Biol Chem; 1994 May; 269(18):13421-8. PubMed ID: 8175773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans.
    Ji ZS; Fazio S; Lee YL; Mahley RW
    J Biol Chem; 1994 Jan; 269(4):2764-72. PubMed ID: 8300609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
    Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
    J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
    Ji ZS; Sanan DA; Mahley RW
    J Lipid Res; 1995 Mar; 36(3):583-92. PubMed ID: 7539827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparan sulfate proteoglycans participate in hepatic lipaseand apolipoprotein E-mediated binding and uptake of plasma lipoproteins, including high density lipoproteins.
    Ji ZS; Dichek HL; Miranda RD; Mahley RW
    J Biol Chem; 1997 Dec; 272(50):31285-92. PubMed ID: 9395455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP).
    Krapp A; Ahle S; Kersting S; Hua Y; Kneser K; Nielsen M; Gliemann J; Beisiegel U
    J Lipid Res; 1996 May; 37(5):926-36. PubMed ID: 8725146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase.
    Choi SY; Komaromy MC; Chen J; Fong LG; Cooper AD
    J Lipid Res; 1994 May; 35(5):848-59. PubMed ID: 8071607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans.
    Huff MW; Miller DB; Wolfe BM; Connelly PW; Sawyez CG
    J Lipid Res; 1997 Jul; 38(7):1318-33. PubMed ID: 9254059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein A-I regulates lipid hydrolysis by hepatic lipase.
    Ramsamy TA; Neville TA; Chauhan BM; Aggarwal D; Sparks DL
    J Biol Chem; 2000 Oct; 275(43):33480-6. PubMed ID: 10944531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
    J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein. Further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG.
    Ji ZS; Mahley RW
    Arterioscler Thromb; 1994 Dec; 14(12):2025-31. PubMed ID: 7526899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
    Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
    J Biol Chem; 1993 May; 268(13):9369-75. PubMed ID: 8387492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of chylomicron remnants and beta-very low density lipoproteins to hepatic and extrahepatic lipoprotein receptors. A process independent of apolipoprotein B48.
    Hui DY; Innerarity TL; Milne RW; Marcel YL; Mahley RW
    J Biol Chem; 1984 Dec; 259(24):15060-8. PubMed ID: 6096356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparan sulfate proteoglycans mediate internalization and degradation of beta-VLDL and promote cholesterol accumulation by pigeon macrophages.
    Seo T; St Clair RW
    J Lipid Res; 1997 Apr; 38(4):765-79. PubMed ID: 9144091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic lipase facilitates the selective uptake of cholesteryl esters from remnant lipoproteins in apoE-deficient mice.
    Amar MJ; Dugi KA; Haudenschild CC; Shamburek RD; Foger B; Chase M; Bensadoun A; Hoyt RF; Brewer HB; Santamarina-Fojo S
    J Lipid Res; 1998 Dec; 39(12):2436-42. PubMed ID: 9831632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cationic domain 141-150 of apoE covalently linked to a class A amphipathic helix enhances atherogenic lipoprotein metabolism in vitro and in vivo.
    Datta G; Garber DW; Chung BH; Chaddha M; Dashti N; Bradley WA; Gianturco SH; Anantharamaiah GM
    J Lipid Res; 2001 Jun; 42(6):959-66. PubMed ID: 11369804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential cellular accumulation/retention of apolipoprotein E mediated by cell surface heparan sulfate proteoglycans. Apolipoproteins E3 and E2 greater than e4.
    Ji ZS; Pitas RE; Mahley RW
    J Biol Chem; 1998 May; 273(22):13452-60. PubMed ID: 9593678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLDL receptor mediates the uptake of human chylomicron remnants in vitro.
    Niemeier A; Gàfvels M; Heeren J; Meyer N; Angelin B; Beisiegel U
    J Lipid Res; 1996 Aug; 37(8):1733-42. PubMed ID: 8864957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of apolipoprotein E variants on lipolysis of very low density lipoproteins by heparan sulphate proteoglycan-bound lipoprotein lipase.
    de Man FH; de Beer F; van de Laarse A; Smelt AH; Leuven JA; Havekes LM
    Atherosclerosis; 1998 Feb; 136(2):255-62. PubMed ID: 9543096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.